Mesenchymal stem cell exosomes therapy for the treatment of traumatic brain injury: mechanism, progress, challenges and prospects
Ming-wei Liu,
No information about this author
Hua Li,
No information about this author
Gang Xiong
No information about this author
et al.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: April 11, 2025
Language: Английский
Metabolic Reprogramming in Cholangiocarcinoma Cancer Stem Cells: Emerging Therapeutic Paradigms
Cancer Letters,
Journal Year:
2025,
Volume and Issue:
unknown, P. 217714 - 217714
Published: April 1, 2025
Language: Английский
The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy
Martina Milella,
No information about this author
Monica Rutigliano,
No information about this author
Savio Domenico Pandolfo
No information about this author
et al.
Cells,
Journal Year:
2025,
Volume and Issue:
14(10), P. 717 - 717
Published: May 15, 2025
Cancer
stem
cells
(CSCs)
are
a
subpopulation
with
self-renewal
and
differentiation
capacities
believed
to
be
responsible
for
tumor
initiation,
progression,
recurrence.
These
exhibit
unique
metabolic
features
that
contribute
their
stemness
survival
in
hostile
microenvironments.
Like
non-stem
cancer
cells,
CSCs
primarily
rely
on
glycolysis
ATP
production,
akin
the
Warburg
effect.
However,
also
show
increased
dependence
alternative
pathways,
such
as
oxidative
phosphorylation
(OXPHOS)
fatty
acid
metabolism,
which
provide
necessary
energy
building
blocks
therapy
resistance.
The
plasticity
of
enables
them
adapt
fluctuating
nutrient
availability
hypoxic
conditions
within
tumor.
Recent
studies
highlight
importance
these
shifts
maintaining
CSC
phenotype
promoting
progression.
model
suggests
small,
metabolically
adaptable
drives
growth
can
switch
between
mitochondrial
enhancing
under
stress
dormant
states.
Targeting
metabolism
offers
promising
therapeutic
strategy;
however,
adaptability
complicates
eradication.
A
multi-targeted
approach
addressing
various
pathways
is
essential
effective
elimination,
underscoring
need
further
research
into
specific
markers
mechanisms
distinguish
from
normal
successful
intervention.
Language: Английский
Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy
Cells,
Journal Year:
2025,
Volume and Issue:
14(10), P. 741 - 741
Published: May 19, 2025
Tumor-associated
macrophages’
(TAMs)
origin,
polarization,
and
dynamic
interaction
in
the
tumor
microenvironment
(TME)
influence
cancer
development.
They
are
essential
for
homeostasis,
monitoring,
immune
protection.
Cells
from
bone
marrow
or
embryonic
progenitors
dynamically
polarize
into
pro-
anti-tumor
M2
M1
phenotypes
based
on
cytokines
metabolic
signals.
Recent
advances
TAM
heterogeneity,
characterization,
immunological
responses,
therapy
described
here.
The
manuscript
details
functions
their
role
resistance
to
PD-1/PD-L1
blockade.
Similarly,
TAM-targeted
approaches,
such
as
CSF-1R
inhibition
PI3Kγ-driven
reprogramming,
discussed
address
immunity
suppression.
Furthermore,
innovative
biomarkers
combination
may
enhance
TAM-centric
therapies.
It
also
stresses
relevance
of
this
distinct
cell
human
health
disease,
which
could
impact
future
research
Language: Английский